Market News

Amgen (AMGN)

Amgen, Inc. and AmerisourceBergen Corp. were sued on Friday by 14 U.S. states and the District of Columbia over an alleged kickback scheme designed to boost sales of Amgen's anemia drug, Aranesp.
New York Attorney General Andrew Cuomo announced the lawsuit, which was filed in federal court in Boston. It joins a related whistleblower lawsuit filed in the same court in 2006 and is one of many lawsuits accusing drugmakers of illegally marketing their products.

Nov 3 · 1:30:00 PM · Source: Reuters · Related: AmerisourceBergen
Track · email · face · Twitter · digg · COMMENTS
by Michael Oliveto

Abbott Labs (ABT)

Abbott announced that it has completed its acquisition of Evalve, Inc., the global leader in the development of devices for minimally invasive repair of mitral valves.
The acquisition provides Abbott with a leading presence in the growing area of non-surgical treatment for structural heart disease. Evalve's minimally invasive catheter-based MitraClip® system is the first commercially available treatment option approved in Europe for non-surgical mitral valve repair for patients suffering from the effects of mitral regurgitation, a condition that prevents the heart's mitral valve from closing completely.

Nov 3 · 11:43:00 AM · Source: Reuters
Track · email · face · Twitter · digg · COMMENTS
by Michael Oliveto

Johnson & Johnson (JNJ)

Johnson & Johnson said Tuesday it will cut up to 7% of its global workforce as part of an ongoing cost-cutting plan that the company says will save between $1.4 and $1.7 billion by 2011. The consumer health product maker has about 117,000 employees spread across more than 250 companies.

Nov 3 · 9:59:00 AM · Source: Company News Release
Track · email · face · Twitter · digg · COMMENTS
by Larry Etter

Humana (HUM)

Humana said Monday that it had third-quarter net income of $301.5 million, or $1.78 per share, compared with $183 million, or $1.09 per share, a year earlier. Revenue rose 8 percent to $7.72 billion.
Analysts had expected $7.82 billion in revenue.

Nov 2 · 1:01:00 PM · Source: Company News Release
Track · email · face · Twitter · digg · COMMENTS
by Larry Etter

Sanofi-Aventis Sa (SNY)

Sanofi-Aventis Friday said its third-quarter net profit rose 6.8% to EUR1.42 billion compared with EUR1.33 billion a year ago. Sales rose 8% to EUR7.4 billion from EUR6.85 billion a year ago.
Sales were above analysts' estimates of EUR7.37 billion

Oct 30 · 8:58:00 AM · Source: Company News Release
Track · email · face · Twitter · digg · COMMENTS
by Larry Etter

Perkin Elmer (PKI)

PerkinElmer Thursday said it posted a net profit from continuing operations of $16 million, or 14 cents per share, compared with a profit of $41.7 million, or 35 cents a share, a year ago. Revenue from continuing operations in the third quarter of 2009 was $437.1 million, a decrease of 9% as compared to the same period a year ago
Profit beats Street views.

Oct 29 · 9:13:00 PM · Source: Company News Release
Track · email · face · Twitter · digg · COMMENTS
by Larry Etter

Allergan (AGN)

Drug company Allergen said its third-quarter earnings increased to $179 million, or 58 cents per share, from $165 million, or 54 cents per share, in the year-earlier period. The company said global sales rose 4.2 percent to $1.13 billion in the quarter, topping analysts' expectations of $1.08 billion
Results were helped by rebound in Botox sales.

Oct 29 · 1:36:00 PM · Source: Company News Release
Track · email · face · Twitter · digg · COMMENTS
by Larry Etter

Astrazeneca PLC (AZN)

AstraZeneca said its net income increased 23 percent to $2.12 billion from $1.73 billion a year earlier. Earnings excluding restructuring and other one-time costs gained to $1.68 a share from $1.32, beating analysts' forecasts. Third-quarter sales gained 5.4 percent to $8.2 billion.
Earnings rose on Swine Flu vaccine.

Oct 29 · 11:33:00 AM · Source: Company News Release
Track · email · face · Twitter · digg · COMMENTS
by Larry Etter

Previous · Next